Picture of Verastem logo

VSTM — Verastem News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Verastem Inc expected to post a loss of 81 cents a share - Earnings Preview

Verastem Inc VSTM.OQ VSTM.O is expected to show a rise in quarterly revenue when it reports  results on March 17 (estimated) for the period ending December 31 2024

The Needham Massachusetts-based  company is expected to report revenue of $150 thousand, according to the mean estimate from 8 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Verastem Inc is for a loss of 81 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Verastem Inc is $13.00‚Äč, above‚Äč its last closing price of $7.21. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDINGSTARMINESMARTESTIMATE¬ģLSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Sep. 30 2024-0.70-0.74-0.60Beat18.7
Jun. 30 2024-0.93-0.95-0.31Beat67.5
Mar. 31 2024-1.03-1.00-1.26Missed-26.4‚Äč
Dec. 31 2023-0.74-0.62-1.02Missed-64.5
‚Äč‚ÄčSep. 30 2023-0.87-0.84-0.75Beat11
Jun. 30 2023-1.07-1.06-1.37Missed-29.2‚Äč
Mar. 31 2023-0.96-0.98-0.96Beat2.4
Dec. 31 2022-1.20-1.18-0.96Beat18.4
This summary was machine generated March 14 at 13:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Verastem

See all news